Fungotac ,10 mg/ml, ear drops, solution
Clotrimazole
This medicine should always be used exactly as described in this patient information leaflet or as directed by your doctor or pharmacist.
Table of contents of the leaflet:
Fungotac is an ear drop solution. The active substance of Fungotac is clotrimazole, which belongs to the group of imidazole medicines. Fungotac has antifungal properties and combats the cause of fungal ear infections.
Fungal infections of the outer and middle ear caused by yeast (of the genus Candida), mold (of the genus Aspergillus), and other fungi.
In case of doubt whether the symptoms in the patient indicate a fungal ear infection, a doctor should be consulted.
If the patient is allergic to clotrimazole or any of the other ingredients of this medicine (listed in section 6).
Before starting to use Fungotac, the patient should discuss it with their doctor, pharmacist, or nurse.
The medicine is intended for topical use in the ear only.
The eyes should be protected from contact with the medicine.
The patient should inform their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
No data available.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
Pregnancy
The use of the medicine during pregnancy is possible only on the doctor's prescription and under their supervision.
Breastfeeding
The use of the medicine in breastfeeding women is possible only on the doctor's prescription and under their supervision.
Fertility
No studies have been conducted on the effect of clotrimazole on human fertility; however, animal studies have not shown any effect of clotrimazole on fertility.
The medicine does not affect the ability to drive or use machines.
This medicine should always be used exactly as described in this patient information leaflet or as directed by the doctor or pharmacist. In case of doubt, the patient should consult their doctor or pharmacist.
The medicine is intended for topical use in the ear.
In the case of a fungal ear infection, 2 or 3 drops of Fungotac should be applied to the ear canal 2 to 3 times a day.
After the acute symptoms of the disease have subsided, treatment should be continued for at least 2 more weeks, until all symptoms have disappeared.
If there is no improvement or the patient feels worse, they should consult their doctor.
There are no reports of clotrimazole overdose when used topically.
If the medicine is swallowed, the patient should immediately consult their doctor.
In case of any further doubts about the use of this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Fungotac can cause side effects, although not everybody gets them.
If an allergic reaction occurs after using Fungotac, the patient should stop using the medicine and immediately consult their doctor. The symptoms of an allergic reaction may include fainting, weakness, difficulty swallowing or breathing, swelling of the lips, face, throat, or tongue, rash (hives).
Frequency not known - cannot be estimated from the available data
After using Fungotac, the patient may experience blisters, discomfort, pain, swelling, redness, irritation, flaking, itching, rash, stinging, or burning sensation.
If the patient experiences any side effects, including any side effects not listed in this leaflet, they should inform their doctor or pharmacist.
Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181 C, 02-222 Warsaw
Phone: +48 22 49-21-301
Fax: +48 22 49-21-309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
There are no special recommendations for the storage temperature of the medicine.
Store in the original packaging to protect from light.
Shelf life after first opening the bottle: 6 months.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of the medicine is clotrimazole. 1 ml of the solution contains 10 mg of clotrimazole.
The other ingredients are: macrogol 400; hydrochloric acid diluted (to adjust the pH to 4.5-7.0), sodium hydroxide (to adjust the pH to 4.5-7.0).
The medicine is a clear, colorless to slightly yellowish solution.
The packaging of the medicine is an HDPE bottle with an HDPE cap, with a tamper-evident seal, containing 20 ml of the solution, with a dropper made of LDPE, in a cardboard box.
Tactica Pharmaceuticals Sp. z o.o.
ul. Królowej Jadwigi 148a/1a
30-212 Kraków
phone: +48 889 388 538
(logo of the marketing authorization holder)
Laboratórios Basi –Indústria Farmacêutica S.A.
Parque Industrial Manuel Lourenco Ferriera, Lotes 8, 15 e 16
3450-232 Mortágua
Portugal
Date of last update of the leaflet:11/2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.